Skip to content
10-Q

Quarterly Report

TONGLI PHARMACEUTICALS (USA), INC.

0001144204-12-008262

← back to feed
Filed
Feb 14, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2011 · Feb 8, 2012 13.41M sh
Stockholders Equity Q3 2011 · Dec 31, 2011 $19.61M
Stockholders Equity Q3 2011 · Mar 31, 2011 $15M
Current Liabilities Q3 2011 · Dec 31, 2011 $1.05M
Current Liabilities Q3 2011 · Mar 31, 2011 $1.79M
Current Assets Q3 2011 · Dec 31, 2011 $6.61M
Current Assets Q3 2011 · Mar 31, 2011 $3.98M
Total Assets Q3 2011 · Dec 31, 2011 $20.66M
Total Assets Q3 2011 · Mar 31, 2011 $17.87M
Operating Cash Flow Q3 2011 · Dec 31, 2010 $2.24M
Sga Expense Q3 2011 · Dec 31, 2010 $136.47K
Sga Expense Q3 2011 · Dec 31, 2010 $567.28K
Net Income Q3 2011 · Dec 31, 2010 $1.43M
Net Income Q3 2011 · Dec 31, 2010 $2.71M
Operating Income Q3 2011 · Dec 31, 2010 $1.95M
Operating Income Q3 2011 · Dec 31, 2010 $3.81M
Gross Profit Q3 2011 · Dec 31, 2010 $2.14M
Gross Profit Q3 2011 · Dec 31, 2010 $4.54M
Cost Of Revenue Q3 2011 · Dec 31, 2010 $2.27M
Cost Of Revenue Q3 2011 · Dec 31, 2010 $5.24M